Data / Drug companies / Hydroquinone
Hydroquinone: 12 companies and 19 products in the FDA NDC directory
Hydroquinone is listed in the FDA National Drug Code Directory by 12 companies, with 19 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; emulsion; kit, and the newest product started marketing on September 13, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 19
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 0
- Routes
- Topical
- Brand names
- Nu-Derm Clear Skin Bleaching and Corrector, Obagi C RX System C Clarifying Serum, Obagi-C Rx System C-Therapy Night Skin Lightening With Vitamins C and E, Olivia Quido Blemish Eraser, Hydro-Q, Nu-Derm Blender Skin Lightener and Blending, Obagi-C Rx System C-Clarifying Serum Normal To Oily Skin Lightening Serum With Vitamin C
- openFDA record search
- api.fda.gov
Companies that list hydroquinone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Obagi Cosmeceuticals LLC | 5 | cream; solution | Other unapproved drugs | January 1, 2010 |
| Zo Skin Health, Inc. | 4 | emulsion; kit | Other unapproved drugs | March 9, 2021 |
| Acella Pharmaceuticals, LLC | 1 | cream | Other unapproved drugs | September 10, 2014 |
| Akron Pharma Inc. | 1 | cream | Other unapproved drugs | September 13, 2024 |
| Apnar Pharma LP | 1 | cream | Other unapproved drugs | November 1, 2021 |
| Bryant Ranch Prepack | 1 | cream | Other unapproved drugs | August 17, 2022 |
| Dermavance Pharmaceuticals | 1 | gel | Other unapproved drugs | December 8, 2008 |
| Marlex Pharmaceuticals, Inc. | 1 | cream | Other unapproved drugs | March 1, 2021 |
| Nivagen Pharmaceuticals, Inc. | 1 | cream | Other unapproved drugs | August 17, 2022 |
| O Skin Care LLC | 1 | cream | Other unapproved drugs | May 4, 2022 |
| Sohm, Inc | 1 | cream | Other unapproved drugs | June 5, 2023 |
| Westminster Pharmaceuticals, LLC | 1 | cream | Other unapproved drugs | April 16, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 12 | 63.2% |
| Emulsion | 3 | 15.8% |
| Kit | 1 | 5.3% |
| Solution | 1 | 5.3% |
| Gel | 1 | 5.3% |
| Liquid | 1 | 5.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 19 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Melanin Synthesis Inhibitor | 18 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.